Two Atlanta defense attorneys say they’re puzzled by the federal government’s decision to prosecute an Iranian professor renowned for stem cell research and two of his former students for alleged trade sanction violations over eight vials of human growth hormone.

They are equally troubled by the circumstances that prompted federal authorities to secretly indict Dr. Masoud Soleimani last year, and a decision to cancel his research visa while he was already en route from Iran to Minnesota to work at the Mayo Clinic. Federal authorities took him into custody when he landed in the U.S. in October.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]